GCM
Gables Capital Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-30
| Closed | -$6.47K | – | 398 |
|
|
2024
Q1 | $6.47K | Hold |
30
| – | – | ﹤0.01% | 341 |
|
|
2023
Q4 | $7.76K | Hold |
30
| – | – | ﹤0.01% | 323 |
|
|
2023
Q3 | $7.71K | Sell |
30
-106
| -78% | -$27.2K | 0.01% | 304 |
|
|
2023
Q2 | $38.7K | Hold |
136
| – | – | 0.03% | 211 |
|
|
2023
Q1 | $37.8K | Hold |
136
| – | – | 0.03% | 214 |
|
|
2022
Q4 | $37.7K | Hold |
136
| – | – | 0.03% | 213 |
|
|
2022
Q3 | $36K | Hold |
136
| – | – | 0.03% | 209 |
|
|
2022
Q2 | $28K | Hold |
136
| – | – | 0.02% | 238 |
|
|
2022
Q1 | $29K | Hold |
136
| – | – | 0.02% | 241 |
|
|
2021
Q4 | $33K | Hold |
136
| – | – | 0.02% | 233 |
|
|
2021
Q3 | $38K | Hold |
136
| – | – | 0.02% | 222 |
|
|
2021
Q2 | $47K | Hold |
136
| – | – | 0.03% | 204 |
|
|
2021
Q1 | $38K | Sell |
136
-10
| -7% | -$2.79K | 0.02% | 238 |
|
|
2020
Q4 | $36K | Hold |
146
| – | – | 0.02% | 224 |
|
|
2020
Q3 | $41K | Hold |
146
| – | – | 0.03% | 211 |
|
|
2020
Q2 | $39K | Hold |
146
| – | – | 0.03% | 202 |
|
|
2020
Q1 | $46K | Buy |
146
+106
| +265% | +$33.4K | 0.04% | 186 |
|
|
2019
Q4 | $12K | Hold |
40
| – | – | 0.01% | 287 |
|
|
2019
Q3 | $9K | Hold |
40
| – | – | 0.01% | 304 |
|
|
2019
Q2 | $9K | Hold |
40
| – | – | 0.01% | 285 |
|
|
2019
Q1 | $9K | Sell |
40
-1,192
| -97% | -$268K | 0.01% | 293 |
|
|
2018
Q4 | $371K | Sell |
1,232
-25
| -2% | -$7.53K | 0.32% | 74 |
|
|
2018
Q3 | $444K | Sell |
1,257
-50
| -4% | -$17.7K | 0.34% | 75 |
|
|
2018
Q2 | $383K | Sell |
1,307
-21
| -2% | -$6.15K | 0.31% | 73 |
|
|
2018
Q1 | $364K | Buy |
+1,328
| New | +$364K | 0.32% | 74 |
|